Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-09-07
1985-12-17
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514914, 514974, A61K 3152
Patent
active
045593434
ABSTRACT:
Xanthine derivatives are described which decrease the stinging associated with the application of ophthalmic acidic anti-inflammatory agents.
REFERENCES:
patent: 2994640 (1961-08-01), Zellner
patent: 3439094 (1969-04-01), Emele
patent: 3632742 (1972-01-01), Eckert et al.
patent: 3957994 (1976-05-01), Schroer
patent: 4141976 (1979-02-01), Voorhees
patent: 4420483 (1983-12-01), Sunshine et al.
J. Pharm. Exp. Thera. 198(2) 481-488 (1976)--Bito et al.
Chem. Abst. 77, 9594(u) (1972)--Riviere.
Chem. Abst. 84, 130,369(x) (1976)--Bourillet et al.
Chem. Abst. 95, 18119(s) (1981)--Fujimura et al.
Abstract B-5 ReBE-897, 356-A and 22.07.82 US 400, 597.
Han Wesley W.
Roehrs Robert E.
Alcon Laboratories Inc.
Robinson Douglas W.
LandOfFree
Nonirritating aqueous ophthalmic compositions comfort formulatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonirritating aqueous ophthalmic compositions comfort formulatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonirritating aqueous ophthalmic compositions comfort formulatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175190